Edenbridge Pharmaceuticals Names Douglas S. Boothe As CEO
12/20/23, 8:02 PM
Location
Industry
pharmaceutical manufacturing
Position
chief executive officer
Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, today announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, 2024
Company Info
Location
parsippany, new jersey, united states
Additional Info
Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.